Mometasone Furoate 83919-23-7

Mometasone furoate is a soft corticosteroid. A soft corticosteroid refers to a type of hormone that is rarely absorbed systemically. Or, when it is absorbed through the skin, it can be rapidly decomposed and metabolized into inactive degradation products, while still maintaining a high level of local activity. It is suitable for use by the elderly, infants and young children, and can be applied to a relatively large skin area.

It is used in the treatment of various inflammatory and allergic conditions. For example, it is commonly used in nasal sprays for the treatment of allergic rhinitis, providing relief from symptoms such as nasal congestion, itching, sneezing, and runny nose. It is also used in topical creams and ointments for skin conditions like eczema, psoriasis, and dermatitis, helping to reduce inflammation, itching, and redness. In addition, it may be used in some inhaled formulations for the treatment of asthma to control airway inflammation and improve lung function.

Anti - Inflammatory Action: Mometasone furoate is a potent corticosteroid with anti - inflammatory, anti - allergic, and immunosuppressive effects. It works by binding to glucocorticoid receptors in the cell cytoplasm, which then translocate to the nucleus and regulate the expression of various genes involved in the inflammatory process. This leads to a reduction in the production of inflammatory mediators such as cytokines, leukotrienes, and prostaglandins, thereby suppressing inflammation.

The dosage of mometasone furoate depends on the specific formulation and the condition being treated. For nasal sprays, the usual recommended dose is one or two sprays in each nostril once daily. For topical applications, a thin layer of the cream or ointment is applied to the affected area once or twice daily. Inhaled formulations for asthma typically have specific dosing regimens based on the patient's age and the severity of the disease, which are usually determined by a healthcare provider.